Pharma Pulse 2/11/25: Revolutionizing Patient Adherence, What Does ‘Cure’ Really Mean? & more
Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement
Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.
The terms “gene therapy” and “cure” go together. Physicians often suggest or outright promise patients that the high-tech treatment will be curative. People with untreatable diseases often pin their hopes on it. A title/abstract search of PubMed, the National Library of Medicine’s database of research articles worldwide, returns more than 1,800 hits containing both terms. But what does “cure” mean?
Pharma Companies Turn to AI to Speed Up Drug Development, But Hit Hurdles
To fulfill AI’s promise, firms are juggling the need to ensure they have the right technical capabilities and people who understand them and data.
T-Mobile, RAM, Liquid Death Awarded Most Engaging Super Bowl LIX Ads
EDO released its annual ranking of all national Super Bowl LIX ads, awarding brands like T-Mobile, RAM, and Liquid Death with the most engaging spots of the night. For a decade, EDO has scored every Super Bowl ad from pre-kick to post-game based on how effective each spot is at driving consumer behaviors — such as website visits and brand searches — immediately after the airing.
Chris Dowd is at it again. This time sharing his pharma knowledge with an insightful article in Pharmaceutical Commerce Magazine about his predictions for how our industry will shift in 2025. Check it out 👇
Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs
